Andrea Bianco, Salvatore D'Antonio, Francesco Paolo Lombardo, Claudio Micheletto, Stefano Palcic, Gherardo Siscaro, Pietro Pirina
{"title":"Single-Inhaler Triple Therapy (SITT) for COPD: An Italian expert opinion paper on improving clinical outcomes and equity of therapeutic access.","authors":"Andrea Bianco, Salvatore D'Antonio, Francesco Paolo Lombardo, Claudio Micheletto, Stefano Palcic, Gherardo Siscaro, Pietro Pirina","doi":"10.5826/mrm.2026.1070","DOIUrl":"10.5826/mrm.2026.1070","url":null,"abstract":"<p><p>Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of global morbidity and mortality, with significant burden in Italy. Prevalence estimates vary by data source: Health Search data indicate a prevalence of 2.7% among adults, whereas population-based analyses report higher estimates of approximately 5.6%. Triple therapy combining a long-acting muscarinic antagonist (LAMA), a long-acting beta2-agonist (LABA), and an inhaled corticosteroid (ICS) has been shown to improve lung function, reduce exacerbations, and potentially decrease mortality in moderate-to-severe COPD. Fixed-dose Single-Inhaler Triple Therapy (SITT) provides practical advantages over Multiple-Inhaler Triple Therapy (MITT), including improved treatment adherence, fewer inhaler technique errors, and comparable safety. This expert opinion review summarizes evidence from randomized controlled trials and real-world studies supporting the clinical, practical, and economic benefits of SITT. While access to SITT in Italy is influenced by regulatory frameworks, optimizing prescription practices and aligning treatment strategies with clinical evidence could enhance continuity of care and patient outcomes. The paper highlights strategies to improve COPD management, reduce treatment discontinuation, and ensure equitable access to effective therapies.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"21 ","pages":"1070"},"PeriodicalIF":2.1,"publicationDate":"2026-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12971106/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147291810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Anna Maria Musolino, Laura Gori, Monica Tei, Maria Chiara Supino, Carmen D'Amore, Marta Ciofi Degli Atti, Lorenzo Di Sarno, Antonella Amendolea, Alessandro Manganaro, Gino Soldati, Francesco Tursi, Danilo Buonsenso, Cristina De Rose, Renato Cutrera, Marco Cirillo, Paolo Tomà, Caterina Bock, Francesco Esposito, Alberto Villani, Vincenzo Colacino, Annarita Iadecola, Paolo Adamoli, Gian Luca Trobia, Alfina Domenica Coco, Giuseppe Limoli, Rino Agostiniani
{"title":"Pediatric lung ultrasound: Tips and tricks for better scanning and interpretation.","authors":"Anna Maria Musolino, Laura Gori, Monica Tei, Maria Chiara Supino, Carmen D'Amore, Marta Ciofi Degli Atti, Lorenzo Di Sarno, Antonella Amendolea, Alessandro Manganaro, Gino Soldati, Francesco Tursi, Danilo Buonsenso, Cristina De Rose, Renato Cutrera, Marco Cirillo, Paolo Tomà, Caterina Bock, Francesco Esposito, Alberto Villani, Vincenzo Colacino, Annarita Iadecola, Paolo Adamoli, Gian Luca Trobia, Alfina Domenica Coco, Giuseppe Limoli, Rino Agostiniani","doi":"10.5826/mrm.2026.1074","DOIUrl":"10.5826/mrm.2026.1074","url":null,"abstract":"<p><p>In recent decades lung ultrasound (LUS) has emerged as an invaluable bedside imaging tool for the evaluation of respiratory conditions such as pneumonia, bronchiolitis, pneumothorax, and pleural effusion in pediatric age, thanks to the thin chest wall and absence of rib ossification. Despite its growing application, optimizing technique and interpretation remains crucial for reliable diagnostic performance. The present educational paper provides practical tips and tricks to enhance the accuracy, efficiency, and clinical value of LUS in pediatric patients, focusing on probe selection, patient positioning, scanning technique, common artifacts, and interpretation pitfalls.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"21 ","pages":"1074"},"PeriodicalIF":2.1,"publicationDate":"2026-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12971107/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146259933","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Timing and predictors of tracheostomy decannulation in COVID-19 and non-COVID-19 ARDS: A real-world study.","authors":"Cinzia Lastoria, Annalisa Carlucci, Francesca Cemmi, Manuela Bergonzi, Abramo Bazza, Roberta Marra, Federica Fioretti, Matteo Vigna, Francesco Tursi, Chiara Mele, Claudia Crimi","doi":"10.5826/mrm.2025.1048","DOIUrl":"10.5826/mrm.2025.1048","url":null,"abstract":"<p><strong>Background: </strong>Tracheostomy is a commonly performed procedure in patients requiring prolonged mechanical ventilation (MV) in Intensive Care Units (ICUs), including COVID-19-related ARDS. However, limited data exist on the timing and predictors of decannulation.</p><p><strong>Aim: </strong>To compare time to decannulation between COVID-19 and non-COVID-19 ARDS patients and to identify predictive factors.</p><p><strong>Methods: </strong>A retrospective study including 96 COVID-19 ARDS and 32 non-COVID-19 ARDS tracheostomized patients admitted to step-down units after ICU stay from March 2020 to May 2021. Clinical, demographic data and comorbidities were analysed as well as predictors for decannulation delay.</p><p><strong>Results: </strong>Timing of decannulation was similar between the two groups. Multivariate analysis identified limb weakness assessed by the Medical Research Council (MRC) scale, duration of steroids therapy, clinical complications, PaO2/FiO2 ratio and smoking history as independent predictors of decannulation timing.</p><p><strong>Conclusions: </strong>COVID-19 did not affect timing of decannulation compared to non-COVID-19 ARDS. ICU-acquired weakness, assessed through the MRC scale, was the strongest predictor of delayed decannulation.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"21 ","pages":"1048"},"PeriodicalIF":2.1,"publicationDate":"2026-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12971105/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146182866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The abstracts of VIII National Congress AdET (Accademia di Ecografia Toracica).","authors":"Various Authors","doi":"10.5826/mrm.2026.1085","DOIUrl":"10.5826/mrm.2026.1085","url":null,"abstract":"<p><p>Pisa, Italy, November 6th-8th Every year, the Accademia di Ecografia Toracia (AdET), an Italian association focused on highlighting the scien-tific relevance of thoracic ultrasound (TUS) in clinical practice, presents the projects of its researchers from across Italy and beyond, in a National Congress where the results from AdET projects are shared and debated. Hereby we report the abstracts of the works submitted for publication.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"21 ","pages":"1085"},"PeriodicalIF":1.6,"publicationDate":"2026-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12971104/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146020407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Antonio Russo, Luigi Massari, Gaetano Rea, Stefano Sanduzzi Zamparelli, Ludovica Capitelli, Fausto De Michele, Marialuisa Bocchino
{"title":"Prevalence and outcomes of SARS-CoV-2 infection in ILD: Post-pandemic study in South Italy.","authors":"Antonio Russo, Luigi Massari, Gaetano Rea, Stefano Sanduzzi Zamparelli, Ludovica Capitelli, Fausto De Michele, Marialuisa Bocchino","doi":"10.5826/mrm.2026.1052","DOIUrl":"10.5826/mrm.2026.1052","url":null,"abstract":"<p><p>This retrospective study assessed the impact of SARS-CoV-2 infection on patients with interstitial lung disease (ILD) at two tertiary centers in Southern Italy between January 2022 and December 2023. The cohort included 282 ILD patients (mean age 69.6 years; 54.9% male), with common diagnoses such as idiopathic pulmonary fibrosis (33.3%) and connective tissue disease-associated ILD (18.7%). SARS-CoV-2 infection occurred in 130 patients (46%), mostly with mild or asymptomatic cases. Pneumonia developed in 18 cases, with 72.2% requiring hospitalization and 5 COVID-19-related deaths. Patients with pneumonia had higher rates of ILD progression (27.7%) and incidental post-infection ILD diagnoses (22.2%) than those with mild infection. Vaccination rates were high, correlating with favorable outcomes in most cases. Importantly, pneumonia cases were often associated with incomplete vaccination or complex comorbidities. Differentiating COVID-19-related lung changes from ILD progression proved challenging, highlighting the importance of specialized radiologic assessment. Excluding COVID-related deaths, mortality rates were similar regardless of infection status, suggesting a degree of resilience among ILD patients. The study concludes that with high vaccine coverage and careful follow-up, most ILD patients had stable outcomes after SARS-CoV-2 infection. However, pneumonia remains a risk factor for adverse outcomes, underscoring the need for long-term, specialized ILD care.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"21 ","pages":"1052"},"PeriodicalIF":2.1,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12971108/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145999606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Serge Ade, Mariano Efio, Josiane Patricia Mapto Foupossia, Ibrahim Mama Cissé, Anthony David Harries
{"title":"What do the clinical and respiratory functional assessments of woodworkers in Parakou, West Africa, reveal?","authors":"Serge Ade, Mariano Efio, Josiane Patricia Mapto Foupossia, Ibrahim Mama Cissé, Anthony David Harries","doi":"10.5826/mrm.2025.1057","DOIUrl":"10.5826/mrm.2025.1057","url":null,"abstract":"<p><strong>Background: </strong>The prevalence of chronic respiratory diseases is increasing globally. Apart from smoking, other contributing factors include occupational exposures, of which wood dust is thought to play a role. This study aimed to investigate relationships between respiratory symptoms or lung function measurements and exposure to wood dust.</p><p><strong>Methods: </strong>This was a prospective and comparative cross-sectional study carried out at Parakou, between June and September 2024. Overall, 108 woodworkers (exposed group) and 108 administrative agents from the city hall, the court and five selected banks (control group) were included. Data were collected on upper and lower respiratory symptoms persisting for at least one week in the last 12 months, demographic and occupational-related characteristics, comorbidities, lifestyles, followed by particulate matter measurements in the workplace and spirometry testing.</p><p><strong>Results: </strong>The mean ages of participants in exposed and control groups were 40±11 and 38±9 years-old, respectively (p=0.163). All were males. Seniority in the profession was longer in the exposed group (18±12 years vs 8±6 years; p<0.001). Workplace ventilation was found inadequate in the exposed group (27% vs 0%; p<0.001). In carpentry, Milicia excelsa (66%) and Afzelia africana (64%) were the types of wood most commonly used. Mean dust levels for PM10, PM2.5 and PM1.0 were 1.4±0.6 mg/m3, 1.2±0.6 mg/m3 and 1.2±0.6 mg/m3, respectively. Cleaning and protection methods for woodworkers included dry sweeping (61%), dust collection devices (7%), personal homemade face-masks (99%), and affiliation to company insurance schemes (12%).No worker had planned check-ups arranged with an occupational physician. Both respiratory symptoms (94% vs 56%; p<0.001) and work-related respiratory symptoms (92% vs 19%; p<0.001) were more common in the exposed versus control group. Exposure to wood dust (aPR=6.8; 95%CI=4.1-11.4; p<0.001) and asthma (aPR=5.4; 95%CI=2.9-10.1; p<0.001) were significantly associated with respiratory symptoms, after adjustment for biomass and passive smoking exposure and length in the profession. The exposed group had a higher prevalence of restrictive disorder suggestive pattern on spirometry than the control group (48% vs 20%; p<0.001).</p><p><strong>Conclusions: </strong>Exposure to wood dust adversely affects respiratory function in woodworkers at Parakou, hence the need to raise awareness among these professionals and identify ways to improve their working conditions.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"20 ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12732326/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145806234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ginanjar Arum Desianti, Dicky Soehardiman, Mia Elhidsi, Tina Reisa, Mohamad Fahmi Alatas, Wahju Aniwidyaningsih, Prasenohadi
{"title":"Transthoracic imaging-guided needle biopsy: 5 years' experience in Indonesia.","authors":"Ginanjar Arum Desianti, Dicky Soehardiman, Mia Elhidsi, Tina Reisa, Mohamad Fahmi Alatas, Wahju Aniwidyaningsih, Prasenohadi","doi":"10.5826/mrm.2025.1046","DOIUrl":"10.5826/mrm.2025.1046","url":null,"abstract":"<p><strong>Background: </strong>Transthoracic needle biopsy (TNB) is one of the routine procedures for thoracic diseases, especially nodules or consolidation. The procedure can be guided by imaging tools, such as computed tomography (CT) scan and ultrasonography (US). This study reports the results of a five-year experience of transthoracic imaging-guided needle biopsy in a respiratory referral hospital.</p><p><strong>Methods: </strong>We searched for a monthly sampling database in the procedure room from 2020 to 2024 and identified all transthoracic imaging-guided needle biopsies, either by CT or US-guided. We excluded a few data samples if there was a repetition of the data register. Data regarding pathology and procedure-related complications were analyzed, with the primary outcomes being disease proportion and positivity rate of the procedure.</p><p><strong>Results: </strong>A total of 1,591 procedures were included in our final analysis. Almost all procedures (99.6%) used a 16-gauge needle core biopsy size. Computed tomography was used predominantly (89.9%) to guide the procedure rather than ultrasound. Adenocarcinoma was the most frequent pathology result of TNB (37.7%). The complications were rare (1.6%) and there was zero mortality reported within 24 hours after TNB procedures. Lung cancer was the most reported case, followed by lymphoma and tuberculosis (TB). The overall accuracy of the TNB procedure in lung and mediastinal consolidation was 96.3%.</p><p><strong>Conclusions: </strong>Transthoracic needle biopsy has high accuracy and is considered a safe procedure with minor complications.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"20 ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12732327/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145783680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"An Italian multidisciplinary Delphi Consensus on new insights about the clinical relevance of Pidotimod.","authors":"Gianluigi Marseglia, Matteo Gelardi, Paola Marchisio, Pierachille Santus, Claudio Ucciferri, Giorgio Ciprandi","doi":"10.5826/mrm.2025.1062","DOIUrl":"10.5826/mrm.2025.1062","url":null,"abstract":"<p><p>Pidotimod is a synthetic dipeptide that modulates both innate and acquired immunity, with the highest number of scientific publications (as documented in PubMed) which have demonstrated its efficacy and safety in different clinical settings. A board of experts promoted a multidisciplinary Delphi Consensus to increase clinicians' knowledge of the possible areas of pidotimod use and also offer useful tools for informed use based on consolidated data. A series of statements concerning the use of pidotimod in different clinical settings and conditions was anonymously voted on by a panel of qualified Italian specialists, including pediatricians, otorhinolaryngologists, allergologists, and pulmonologists, using a web platform. All the statements obtained full agreement from the panel about the scientific value of evidence on pidotimod efficacy and safety in managing children and adults with recurrent respiratory infections, both in prevention and add-on therapy. In addition, there was agreement about the use of pidotimod in specific situations, including combined therapy (antibiotics plus pidotimod) for pneumonia, Down syndrome, COVID-19, PFAPA, wheezing, and urinary infections. In conclusion, pidotimod is a safe and effective drug helpful in preventing recurrent respiratory infections in susceptible patients and as an adjuvant in managing patients with infections.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"20 ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12732328/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145650011","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Is the combination of Myelodysplastic syndromes and pulmonary fibrosis accidental or inevitable?","authors":"Yang He, Yahua Li, Yuanyuan Wang, Jinqiao Zhang, Haiying Chen, Jiequn Chen, Yunxia Zhao","doi":"10.5826/mrm.2025.1056","DOIUrl":"10.5826/mrm.2025.1056","url":null,"abstract":"<p><strong>Introduction: </strong>We diagnosed and managed a patient with pulmonary fibrosis combined with myelodysplastic syndrome (MDS). This paper aims to investigate, through analysis of our clinical case, a review of the existing literature, and relevant genetic analyses, whether the concurrent occurrence of pulmonary fibrosis and MDS represents a clinical coincidence or reflects an underlying shared pathogenetic mechanism.</p><p><strong>Case presentation: </strong>A 64-year-old male farmer with concurrent MDS and interstitial pulmonary fibrosis underwent whole-exome sequencing, which revealed abnormalities in the MTHFR, PCSK9, and IFIH1 genes. A literature review demonstrated that these three genes are associated with both MDS and pulmonary fibrosis. A search of previous literature identified six similar case reports over a 22-year period, suggesting that the concurrent occurrence of these two conditions may be linked to CD68+ cells, myeloperoxidase (MPO)-positive inflammatory cells, VEXAS syndrome, telomere diseases, and other factors.</p><p><strong>Conclusion: </strong>MTHFR, IFIH1, PCSK9 and CTC1 are involved in key pathways including folate metabolism, immune regulation, inflammatory responses and telomere disorders, which may contribute to the pathogenesis of both MDS and pulmonary fibrosis. The coexistence of these two conditions is likely attributed to complex interactions among multiple gene mutations, environmental triggers, and dysregulated immune processes, rather than a single.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"20 ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12674183/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145607349","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Fabiano Di Marco, Federico Raimondi, Gianluca Imeri, Christian Mazzola, Simone Pappacena, Simone Vargiu, Michele Capelli, Giorgio Lorini, Juan Camilo Signorello, Paolo Solidoro, Dejan Radovanovic, Luca Novelli
{"title":"Unmasking hypoxemia: the role of standard PaO₂ in interpreting Arterial blood gas analysis.","authors":"Fabiano Di Marco, Federico Raimondi, Gianluca Imeri, Christian Mazzola, Simone Pappacena, Simone Vargiu, Michele Capelli, Giorgio Lorini, Juan Camilo Signorello, Paolo Solidoro, Dejan Radovanovic, Luca Novelli","doi":"10.5826/mrm.2025.1055","DOIUrl":"10.5826/mrm.2025.1055","url":null,"abstract":"<p><strong>Background: </strong>In the assessment of acute respiratory failure (ARF), PaO2/FIO2 ratio is widely used, but may be misleading in the presence of hyperventilation-induced hypocapnia. The standard PaO2 (stPaO2), a theoretical value corrected for PaCO2, may improve clinical interpretation of gas exchange severity.</p><p><strong>Methods: </strong>We conducted an online survey among Italian physicians using a case vignette of three hypothetical patients with identical PaO2 values but differing PaCO2 levels. Participants were asked to rank the severity of the cases based solely on arterial blood gas analysis (ABG). A second round was offered after introducing the concept of stPaO2 and providing corresponding values.</p><p><strong>Results: </strong>A total of 2,241 (8.9%) physicians (median age 53 years, 54.1% male) completed the first round and 1,324 (59%) completed the second one of the survey. Initially, only 9.2% correctly identified the clinical severity pattern-this increased significantly to 16.1% after introducing stPaO2 (p < 0.01). The improvement rate was higher among physicians with less than 10 years of clinical experience. Performance improved across all specialties, particularly in emergency and intensive care medicine.</p><p><strong>Conclusions: </strong>The introduction of stPaO2 significantly enhanced physicians' ability to interpret ABG results in ARF. Although its calculation assumes ideal physiological conditions, stPaO2 remains a useful tool for unmasking hypoxemia in hyperventilating patients. Including stPaO2 in ABG reports may support more accurate clinical decision-making, particularly in emergency and critical care settings.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"20 ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12674182/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145497415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}